| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |